Lindsey Guidry
Family Medicine · Lafayette, LANPI 1215497235
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 387 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations.
Across 387 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$842
- Lilly USA, LLC$526
- AbbVie$454
- Amgen$385
- Corium, LLC$310
- plus $3K from 29 others
What the payments were for
- Food & beverage$6,513100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 61 | $1,145 |
| GSK | 56 | $842 |
| Lilly USA, LLC | 33 | $526 |
| AbbVie | 26 | $454 |
| Amgen | 22 | $385 |
| Corium, LLC | 28 | $310 |
| Novo Nordisk | 16 | $251 |
| Antares Pharma, Inc. | 12 | $250 |
| Astellas Pharma US Inc | 13 | $246 |
| Pfizer | 10 | $200 |
| Noven Therapeutics, LLC | 10 | $200 |
| Exact Sciences | 11 | $193 |
| Phathom Pharmaceuticals, Inc. | 10 | $153 |
| Esperion Therapeutics, Inc. | 10 | $150 |
| Shield Therapeutics Inc | 16 | $146 |
| Axsome Therapeutics, Inc. | 4 | $116 |
| Verona Pharma, Inc. | 4 | $93 |
| Bayer | 5 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $82 |
| Valinor Pharma, LLC | 4 | $74 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $73 |
| Abbott | 3 | $71 |
| Dexcom, Inc. | 2 | $66 |
| Merck | 4 | $64 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 3 | $52 |
| Halozyme Inc | 3 | $48 |
| Tolmar, Inc. | 2 | $35 |
| Tris Pharma Inc | 2 | $30 |
| Biogen | 1 | $25 |
| Viatris Specialty LLC | 1 | $23 |
| Global Blood Therapeutics, Inc. | 1 | $22 |
| Novartis | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| Ardelyx, Inc. | 1 | $14 |
How this compares
$6,513 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 119 | $154,979 |
| FarxigaDapagliflozin Propanediol | 31 | $24,474 |
| TrulicityDulaglutide | 18 | $18,882 |
| OzempicSemaglutide | 12 | $18,498 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $16,602 |
| EliquisApixaban | 22 | $14,597 |
| LinzessLinaclotide | 21 | $13,149 |
| JanuviaSitagliptin Phosphate | 15 | $13,065 |
| Repatha SureclickEvolocumab | 12 | $11,007 |
| MyrbetriqMirabegron | 13 | $9,360 |
| MovantikNaloxegol Oxalate | 17 | $8,570 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,902 |
| Colchicine | 15 | $1,877 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 119 | $1,067 |
| Armour ThyroidThyroid,pork | 11 | $1,010 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $526 | $173,861137 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,145 | $31,37642 claims |
| Novo NordiskOzempic | $251 | $18,49812 claims |
| GSKTrelegy Ellipta | $842 | $16,60220 claims |
| PfizerEliquis | $200 | $14,59722 claims |
| AbbVieLinzess, Armour Thyroid | $454 | $14,15932 claims |
| MerckJanuvia | $64 | $13,06515 claims |
| Astellas Pharma US IncMyrbetriq | $246 | $9,36013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Lafayette
- Geoffrey MireLafayette$13K
- Darrin MenardLafayette$13K
- Christine SmithBaton Rouge$185K
- Thomas DansbyMonroe$169K
- Michael FlemingShreveport$165K
- Robert St AmantGonzales$156K
- William HathawaySpringhill$105K
- Cesar GonzalesWest Monroe$94K
- Phillip ConnerSulphur$71K
- Richard JeansonneMandeville$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.